Form 4 for INSM INSMED Inc
Accepted 2023-01-12 00:00:00 ET · period of report 2023-01-10 · accession 0001628280-23-000963 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-12 | 2023-01-10 | INSM | Wise John Drayton | Chief Commercial Off | S - Sale | $17.96 | -779 | 77.3K | -1.0% | -$14.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-10 | S | D | 779 | $17.96 | 77,272 | D | — | — | (F2) This is the weighted average sales price representing 779 shares sold at prices ranging from $17.93 to $17.98 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |